NBTX
Nanobiotix
NBTX
NBTX
7 hedge funds and large institutions have $28.8M invested in Nanobiotix in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$48K |
| 3 |
3
Millennium Management
New York
|
$101K |
| 4 |
WP
4
Woodline Partners
San Francisco,
California
|
$345K |
| 5 |
5
Morgan Stanley
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $11.6M | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $8.58M | – | – | – |
|
|
AG
3
Artal Group
Luxembourg
| $8.1M | – | – | – |
|
|
WP
4
Woodline Partners
San Francisco,
California
| $345K | -$73.4K | -9,063 | -18% |
|
|
5
Millennium Management
New York
| $101K | -$78.7K | -9,521 | -44% |
|
|
6
UBS Group
Zurich,
Switzerland
| $48K | -$434K | -54,340 | -90% |
|
|
AWM
7
Activest Wealth Management
Aventure,
Florida
| $2K | – | – | – |
|
|
O
8
OrbiMed
New York
| – | -$5.68M | -500,000 | Closed |
|
|
9
Morgan Stanley
New York
| – | -$3K | -300 | Closed |
|